Ved at øge de endogene niveauer af disse inkretinhormoner øger vildagliptin betacellernes følsomhed over for glukose, og dermed forbedres den glukoseafhængige insulinsekretion.
By increasing the endogenous levels of these incretin hormones, vildagliptin enhances the sensitivity of beta cells to glucose, resulting in improved glucose-dependent insulin secretion.